Increased expression of CD133 and reduced dystroglycan expression are strong predictors of poor outcome in colon cancer patients. (Q36523671)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22964035%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

title

Increased expression of CD133 and reduced dystroglycan expression are strong predictors of poor outcome in colon cancer patients (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22964035%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

1 reference

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22964035%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

author name string

Claudio Coco

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22964035%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Gian Franco Zannoni

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22964035%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Emanuele Caredda

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22964035%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Stefano Sioletic

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22964035%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Alma Boninsegna

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22964035%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Mario Migaldi

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22964035%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Gianluca Rizzo

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22964035%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Luca Reggiani Bonetti

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22964035%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Giannicola Genovese

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22964035%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Egidio Stigliano

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22964035%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Achille Cittadini

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22964035%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

publication date

11 September 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22964035%20AND%20SRC:MED&resulttype=core&format=json

Journal of Experimental & Clinical Cancer Research

12 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22964035%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

volume

31

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22964035%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

page(s)

71

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22964035%20AND%20SRC:MED&resulttype=core&format=json

Differential CD133 expression pattern during mouse colon tumorigenesis

12 February 2020

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3541988

CD133 protein N-glycosylation processing contributes to cell surface recognition of the primitive cell marker AC133 epitope

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3541988

Identification of Endothelin-1 and NR4A2 as CD133-regulated genes in colon cancer cells

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3541988

Inconsistent immunohistochemical expression patterns of four different CD133 antibody clones in glioblastoma

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3541988

A tumor suppressor function of laminin-binding alpha-dystroglycan

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3541988

More than markers: biological significance of cancer stem cell-defining molecules

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3541988

The AC133 epitope, but not the CD133 protein, is lost upon cancer stem cell differentiation

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3541988

CD133 gene overexpression is frequently observed in early colorectal carcinoma

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3541988

Prognostic significance of the cancer stem cell markers CD133, CD44, and CD166 in colorectal cancer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3541988

The cancer stem cell marker CD133 has high prognostic impact but unknown functional relevance for the metastasis of human colon cancer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3541988

Higher percentage of CD133+ cells is associated with poor prognosis in colon carcinoma patients with stage IIIB

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3541988

Loss of alpha-dystroglycan laminin binding in epithelium-derived cancers is caused by silencing of LARGE.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3541988

Expression of beta-dystroglycan is reduced or absent in many human carcinomas

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3541988

CD133 expression is an independent prognostic marker for low survival in colorectal cancer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3541988

CD133 expression is not restricted to stem cells, and both CD133+ and CD133- metastatic colon cancer cells initiate tumors

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3541988

Dystroglycan expression is reduced during prostate tumorigenesis and is regulated by androgens in prostate cancer cells

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3541988

A human colon cancer cell capable of initiating tumour growth in immunodeficient mice

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3541988

Identification and expansion of human colon-cancer-initiating cells

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3541988

Altered expression of alpha-dystroglycan subunit in human gliomas

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3541988

Expression of the CDK inhibitor p27kip1 and oxidative DNA damage in non-neoplastic and neoplastic vulvar epithelial lesions

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3541988

Analysis of dystroglycan regulation and functions in mouse mammary epithelial cells and implications for mammary tumorigenesis

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3541988

The dystroglycan complex: from biology to cancer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3541988

The staging of colorectal cancer: 2004 and beyond

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3541988

Proteolytic enzymes and altered glycosylation modulate dystroglycan function in carcinoma cells.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3541988

Aberrant expression, processing and degradation of dystroglycan in squamous cell carcinomas.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3541988

Dystroglycan complex in cancer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3541988

Dystroglycan in skin and cutaneous cells: beta-subunit is shed from the cell surface

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3541988

Dystroglycan expression is frequently reduced in human breast and colon cancers and is associated with tumor progression.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3541988

A role for dystroglycan in epithelial polarization: loss of function in breast tumor cells.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3541988

The complexities of dystroglycan

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3541988

Anomalous dystroglycan in carcinoma cell lines.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3541988

Expression of CD133 correlates with differentiation of human colon cancer cells.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3541988

Dystroglycan is required for polarizing the epithelial cells and the oocyte in Drosophila.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3541988

Immunohistochemical detection of CD133 expression in colorectal cancer: a clinicopathological study.

28 June 2018

1 reference

https://api.crossref.org/works/10.1186%2F1756-9966-31-71

Reduced α-dystroglycan expression correlates with shortened patient survival in pancreatic cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1756-9966-31-71

Co-expression of stem cell genes CD133 and CD44 in colorectal cancers with early liver metastasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1756-9966-31-71

Is CD133 a biomarker for cancer stem cells of colorectal cancer and brain tumors? A meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1756-9966-31-71

Post-translational modulation of CD133 expression during sodium butyrate-induced differentiation of HT29 human colon cancer cells: implications for its detection

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3541988

Increased expression of dystroglycan inhibits the growth and tumorigenicity of human mammary epithelial cells.

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3541988

Dystroglycan is associated with tumor progression and patient survival in gastric cancer

21 September 2018

1 reference

12 December 2020

Biosynthesis of dystroglycan: processing of a precursor propeptide

1 reference

12 December 2020

Reduced expression of dystroglycan in breast and prostate cancer

1 reference

12 December 2020

Clinicopathological significance and prognostic value of EphA3 and CD133 expression in colorectal carcinoma

1 reference

12 December 2020

Aberrant expression of alpha-dystroglycan in cervical and vulvar cancer

1 reference

12 December 2020

Isolation and characterization of CD133+ cell population within human primary and metastatic colon cancer

1 reference

12 December 2020

Divergent expression of CD133 in different studies: the need for a consensus panel?

1 reference

12 December 2020

Identifiers

DOI

10.1186/1756-9966-31-71

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22964035%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

12 February 2020

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22964035%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

PubMed publication ID

22964035

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22964035%20AND%20SRC:MED&resulttype=core&format=json